Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
AstraZeneca
QuintilesIMS
Chubb
Cantor Fitzgerald
Dow
Queensland Health
Boehringer Ingelheim
Accenture

Generated: February 21, 2018

DrugPatentWatch Database Preview

Methdilazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for methdilazine and what is the scope of methdilazine freedom to operate?

Methdilazine
is the generic ingredient in two branded drugs marketed by Westwood Squibb and Alpharma Us Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for methdilazine.
Summary for methdilazine

US Patents and Regulatory Information for methdilazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb TACARYL methdilazine hydrochloride TABLET;ORAL 011950-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Westwood Squibb TACARYL methdilazine hydrochloride SYRUP;ORAL 011950-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms METHDILAZINE HYDROCHLORIDE methdilazine hydrochloride SYRUP;ORAL 087122-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Westwood Squibb TACARYL methdilazine TABLET, CHEWABLE;ORAL 011950-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Express Scripts
Fuji
McKesson
Federal Trade Commission
Johnson and Johnson
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot